Skip to main content
. 2024 Mar 11;46(1):2327495. doi: 10.1080/0886022X.2024.2327495

Figure 6.

Figure 6.

QCT protected HK-2 cells against ferroptosis via Nrf2. (A) Western blot analyses of GPX4, xCT and ACSL4 in each group of HK-2 cells. (B–D) Semi-quantitative assessments of GPX4, xCT, and ACSL4 from immunoblots. (E) HK-2 cell viability across various treatment groups (CON, HG, HG + QCT, HG + Fer-1 and HG + QCT + ML385) assessed via CCK-8 assay. (F–I) Quantitative PCR results showing relative mRNA expressions of GPX4, xCT, ACSL4, and Nrf2 in the cells from each group. CON: control HK-2 cells; HG: HK-2 cells under HG incubation; HG + QCT: HK-2 cells under HG incubation receiving quercetin treatment; HG + QCT + ML385: HK-2 cell under HG incubation receiving quercetin and ML385 treatment. Data are mean ± SD. Significance levels are indicated as follows: ****p < 0.0001; ***p < 0.001; **p < 0.01; *p < 0.05, determined by one-way ANOVA.